Form of Award NoticeAward Notice • February 19th, 2015 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 19th, 2015 Company Industry JurisdictionThis notice of Award (the “Award Notice”) sets forth certain details relating to the grant by the Company to you of the Award identified below, pursuant to the Plan. The terms of this Award Notice are incorporated into the Agreement that accompanies this Award Notice and made part of the Agreement. Capitalized terms used in this Award Notice that are not otherwise defined in this Award Notice have the meanings given to such terms in the Agreement.
Form of Award NoticeAward Notice • February 19th, 2015 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 19th, 2015 Company Industry JurisdictionThis notice of Award (the “Award Notice”) sets forth certain details relating to the grant by the Company to you of the Award identified below, pursuant to the Plan. The terms of this Award Notice are incorporated into the Agreement that accompanies this Award Notice and made part of the Agreement. Capitalized terms used in this Award Notice that are not otherwise defined in this Award Notice have the meanings given to such terms in the Agreement.
AMENDMENT NO. 1 TO THE COLLABORATION AGREEMENTCollaboration Agreement • February 19th, 2015 • Amgen Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 19th, 2015 Company Industry JurisdictionThis Amendment No. 1 to the Collaboration Agreement (this “Amendment”) is entered into as of the 1st day of October, 2014 (the “Amendment Effective Date”) by and between Amgen Inc., a Delaware corporation with a place of business at One Amgen Center Drive, Thousand Oaks, California 91320 (“Amgen”), and AstraZeneca Collaboration Ventures, LLC, a Delaware limited liability company with a place of business at 1800 Concord Pike, Wilmington, Delaware 19850 (“Partner”). Amgen and Partner are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. AstraZeneca Pharmaceuticals LP, the parent corporation of Partner (“AstraZeneca”), [*] of the Agreement (as defined below) is a party to this Amendment [*].